![Justin Ferdinandus: BrECADD is better tolerated than eBEACOPP for patients with advanced Hodgkin Lymphoma](https://oncodaily.com/pub/uploads/2024/07/IMG_3759-e1720201280824.jpeg)
Photo taken from Justin Ferdinandus/X
Jul 6, 2024, 09:58
Justin Ferdinandus: BrECADD is better tolerated than eBEACOPP for patients with advanced Hodgkin Lymphoma
Justin Ferdinandus, Resident Physician at University Hospital Cologne, shared on X:
“HD21 results now finally published in The Lancet:
BrECADD is better tolerated and more efficient than eBEACOPP as PET-guided treatment for patients with adv. Hodgkin Lymphoma!”
Source: Justin Ferdinandus/X
Aug 29, 2024, 20:47